|
|
Ogilvie GK, Moore AS: Managing the Canine Cancer Patient: A Comprehensive Guide to Compassionate Care. Veterinary Learning Systems Books. Trenton, NJ, 2006.
Ogilvie GK, Moore AS: Feline Oncology: A Comprehensive Guide to Compassionate Care. Veterinary Learning Systems (VLS Books). Trenton, NJ, 2001.
Feline Oncology: A Comprehensive Guide to Compassionate Care. Published in Japanese by Interzoo, Tokyo. 2003.
Ogilvie GK, Moore AS. Managing the Veterinary Cancer Patient: A Practice Manual. Veterinary Learning Systems (VLS Books). Trenton, NJ. 1995.
Managing the Veterinary Cancer Patient: A Practice Manual. Published in Japanese by LLL Seminar, Tokyo. 1995
Manuel Pratique de Cancerologie Veterinaire. Published in French by Masson Edition du Point Veterinaire, Paris. 1997.
Moore AS. Practical Chemotherapy. Textbook of Veterinary Internal Medicine Sixth Edition (SJ Ettinger and EC Feldman eds) WB Saunders Co., Philadelphia. 2005
Moore AS, Kitchell BE. New chemotherapy drugs in veterinary medicine. Veterinary Clinics of North America: Small Animal Practice. Update in Medical Oncology. Elsevier Science. Philadelphia. 33: 629-649, 2003
Moore AS, Frimberger AE. Principles of Chemotherapy. Textbook of Veterinary Internal Medicine Fifth Edition (SJ Ettinger and EC Feldman eds) WB Saunders Co., Philadelphia. 484-489, 1999
Moore AS, Mahony O. Treatment of Feline Malignant Lymphoma. In: Current Veterinary Therapy XII. Small Animal Practice (RW Kirk, JD Bonagura eds) WB Saunders, Philadelphia. 498-502, 1995
Moore AS. Treatment of Cancer in Companion Animals. University of Sydney Postgraduate Committee in Veterinary Science, Proceedings 224, 1994.
Leveille C, Moore AS. Multiple Drug Resistance. Advances Vet Science Compar Med 37 31-59, 1993
Moore AS. Chemotherapy for intrathoracic cancer in dogs and cats. Problems Vet Med 4 351-364, 1992
Ogilvie GK, Moore AS. Mitoxantrone chemotherapy in small animals. In: Current Veterinary Therapy XI. Small Animal Practice (RW Kirk, JD Bonagura eds) WB Saunders, Philadelphia. 399-402, 1992
Moore AS, deSouza PL, Imondi AR, Wood CA. Intravenous administration of 9-aminocamptothecin (9-AC) to dogs with lymphoma. Veterinary and Comparative Oncology 1, 86-93, 2003
Moore AS, Beam SL, Rassnick KM, Provost PJ. Long-term control of metastatic mucocutaneous squamous cell carcinoma of the lip in a horse using piroxicam. Equine Veterinary Journal 35, 715-718, 2003
Moore AS, Nelson RW, Henry CJ, Rassnick KM, Kristal O, Ogilvie GK, Kintzer P. Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999). J Am Vet Med Assoc 221, 811-818, 2002.
Moore AS. Radiation therapy for the treatment of tumours in small companion animals. The Veterinary Journal 164, 176-187, 2002.
Moore AS. Osteosarcoma in dogs: managing a destructive disorder. Veterinary Medicine 161 539-546, 2001.
Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA, Frimberger AE, Gliatto J, L’Heureux DA. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Internal Med 15 348-354, 2001.
Moore AS, Wood CA, Engler SJ, Bengtson AE. Radiation therapy for long-term control of odontogenic tumours and epulis in three cats. J Feline Med Surg 2 57-60, 2000.
Moore AS, London CA, Wood CA, Williams LE, Cotter SM, L'Heureux DA, Frimberger AE. Lomustine (CCNU) for the treatment of relapsed lymphoma in dogs. J Vet Internal Med 13 395-398, 1999.
Moore AS. Advances in the treatment of canine and feline lymphoma. Modern Veterinary Medicine 8 (42) 6-13, 1999.
Moore AS, Cotter SM, Frimberger AE, Wood CA, L'Heureux DA. A comparison of doxorubicin vs. COP for maintenance of remission in cats treated for lymphoma. J Vet Internal Med 10 372-375, 1996.
Moore AS. Treatment of feline lymphoma. Feline Practice 24 (6) 17-20, 1996.
Moore AS, Leveille CR, Reimann KA, Shu H, Arias IM. The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Investigation 13 475-479, 1995.
Moore AS, Ruslander D, Cotter SM, Rand WM, L'Heureux DA. Efficacy of and toxicoses associated with oral idarubicin administration in cats with neoplasia. J Am Vet Med Assoc 206 1550-1554, 1995.
Moore AS, Ogilvie GK, Vail DM. Actinomycin D for reinduction of remission in dogs with resistant lymphoma. J Vet Internal Med 8 343-344, 1994.
Moore AS, Rand WM, Berg J, L'Heureux DA, Dennis RA. Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs. J Am Vet Med Assoc 205 441-443, 1994.
Moore AS, Ogilvie GK, Ruslander D, Rand WS, Cotter SM, Getzy DM, L'Heureux DA, Dennis RA. Evaluation of mitoxantrone for the treatment of lymphoma in dogs. J Am Vet Med Assoc 204 1903-1905, 1994.
Moore AS. Recent advances in chemotherapy for non-lymphoid malignancies. Compend Contin Educ Pract Veterinarian. 15 1039-1052, 1993.
Moore AS, Kirk C, Cardona A; Intracavitary cisplatin chemotherapy: experience with six dogs. J Vet Internal Med 5 227-231, 1991.
Moore AS, Theilen GH, Newell AD, Madewell BR, Rudolf AR. Preclinical study of sequential tumor necrosis factor and interleukin 2 in the treatment of spontaneous canine neoplasms. Cancer Research 51 233-238, 1991.
Moore AS, Cardona A, Madewell BR; Cisplatin (cisdiammine dichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra; a retrospective study of 15 dogs. J Vet Internal Med 4 148-156, 1990.
Moore AS, Madewell BR, Cardinet III GH, Shelton GD: Osteogenic sarcoma and myasthenia gravis in a dog. J Am Vet Med Assoc 197 226-227, 1990.
Moore AS, Madewell BR, Lund JK; The immunohistochemical evaluation of intermediate filament expression in canine and feline neoplasms. Amer J Vet Research 50 88-92, 1989.
Moore AS, Middleton DJ; Pulmonary adenocarcinoma in three cats with non-respiratory signs only. J Small Animal Practice 23 501-509, 1982.
Simon D, Ruslander DM, Rassnick KM, Wood CA, A.E. Frimberger AE, Cotter SM, King NW, Moore AS. Orthovoltage radiation therapy and concurrent weekly low-dose doxorubicin for incompletely excised soft-tissue sarcomas in 39 dogs Vet Record in press
Rassnick KM, Moore AS, Northrup NC, Kristal O, Beaulieu BB, Lewis LD, Page RL. Phase I and pharmacokinetic study of ifosfamide in cats with soft tissue sarcomas. Am J Vet Research in press
Frimberger AE, Moore AS, Rassnick KM, Cotter SM, O’Sullivan JL, Quesenberry PJ. A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma. J Vet Internal Med in press
MacGregor JM, Faria MLE, Moore AS, Tobias AH, Brown DJ, Morais HSA. Primary cardiac lymphoma causing pericardial effusion in dogs: 12 Cases (1997-2004). J Am Vet Med Assoc in press.
Cahalane AK, Payne S, Barber LG, Duda LE, Henry CJ, Mauldin GE, Frimberger AE, Cotter SM, Moore AS. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J Am Vet Med Assoc 225, xxx-xxx, 2004
Payne SE, Rassnick KM, Northrup NC, Kristal O, Chretin JD, Cotter SM, Kintzer P, Frimberger AE, Morrison-Collister KE, Wood CA, Moore AS. Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin. Veterinary and Comparative Oncology 1, 171-179, 2004
Morrison-Collister KE, Rassnick KM, Northrup NC, Kristal O, Chretin JD, Williams LE, Cotter SM, Moore AS. A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma. Veterinary and Comparative Oncology 1, 180-190, 2004
Snyder LA, Bertone ER, Dooner MS, Jennings J, Jakowski R, Moore AS. P53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Veterinary Pathology 41,209-214, 2004
Kristal O, Rassnick KM, Gliatto JM, Northrup NC, Chretin JD, Morrison-Collister K, Cotter SM, Moore AS, Hepatotoxicity associated with CCNU (Lomustine) chemotherapy in dogs. J Vet Internal Med 18, 75-80, 2004
Williams LE, Gliatto JM, Dodge RK, Gamblin RM, Thamm DH, Lana SE, Szymkowski M, Moore AS. Canine carcinoma of the apocrine glands of the anal sac: 113 cases (1985-1995). J Am Vet Med Assoc 223,825-831, 2003
Beam SL, Rassnick KM, Moore AS, McDonough SP. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 40, 496-500, 2003
Penninck D, Smyers B, Leveille-Webster CR, Rand W, Moore AS. Diagnostic value of ultrasonography in differentiating enteritis from intestinal neoplasia in dogs. Vet Radiology and Ultrasound 44, 570-575, 2003
Bertone ER, Snyder LA, Moore AS. Risk factors for oral squamous cell carcinoma in cats. J Vet Internal Med 17, 557-562, 2003.
Clancy EA, Moore AS, Bertone ER Feline and owner characteristics and outdoor access of owned cats. J Am Vet Med Assoc 222, 1541-1545, 2003.
Rassnick KM, Mauldin GE, Al-Sarraf R, Mauldin GN, Moore AS, and Mooney SC. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000) J Vet Internal Med 16, 576-580, 2002.
Bertone ER, Snyder LA, Moore AS. Environmental tobacco smoke and risk of malignant lymphoma in pet cats. Am J Epidemiology 156, 268-273, 2002.
Paoloni MC, Penninck DG, Moore AS. Ultrasonographic and clinicopathologic findings in 21 dogs with intestinal adenocarcinoma. Vet Radiology and Ultrasound 43, 562-567, 2002.
Northrup NC, Rassnick KM, Snyder LA, Kristal O, Cotter SM, Moore AS. Neutropenia associated with vincristine and Lasparaginase induction chemotherapy for canine lymphoma. J Vet Internal Med 16, 570-575, 2002.
Ogilvie GK, Moore AS. Endocrine manifestations of malignancy in cats. Compendium on Continuing Education for the Practicing Veterinarian 23 1042-1048, 2001.
Rassnick KM, Ruslander DM, Cotter SM, Al-Sarraf R, Bruyette DS, Gamblin RM, Meleo KA, Moore AS. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000). J Am Vet Med Assoc 218 1444-1448, 2001.
Rassnick KM, Geiger TL, Williams LE, Ruslander DM, Northrup NC, Kristal O, Myers NC, Moore AS. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats. J Vet Internal Med 15 196-199, 2001.
Kristal O, Lana SE, Ogilvie GK, Cotter SM, Moore AS. Single agent chemotherapy with doxorubicin for feline lymphoma. J Vet Internal Med 15 125-130, 2001.
Northrup NC, Etue S, Ruslander D, Rassnick KM, Hutto DL, Bengston A, Rand W, Moore AS. Retrospective study of orthovoltage radiation for nasal tumors in 42 dogs. J Vet Internal Med 15 183-189, 2001.
Luna LD, Henry CJ, Higginbotham ML, Turnquist SE, Moore AS, Graham JC. Feline non-ocular melanoma: a retrospective study of 23 cases. (1991-1999). J Feline Med Surg 4 173-181, 2000.
Valli VE, Jacobs RM, Norris A, Couto CG, Morrison WB, McCaw D, Cotter SM, Ogilvie GK, Moore A. The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation. J Vet Diagnostic Investigation 12 295-306, 2000.
Rassnick KM, Frimberger AE, Wood CA, Williams LE, Cotter SM, Moore AS. Evaluation of ifosfamide for treatment of various canine neoplasms. J Vet Internal Med 14 271-276, 2000.
Burgess K, Moore AS, Rand WM, Cotter SM. Immune mediated hemolytic anemia in dogs: a retrospective study of 60 cases treated with cyclophosphamide (1989-1994. J Vet Internal Med 14 456-462, 2000.
Rassnick KM, Moore AS, Williams LE, London CA, Kintzer PP, Cotter SM. Treatment of canine mast cell tumors with CCNU. J Vet Internal Med 13 601-605, 1999.
Zemann B, Moore AS, Rand WM, Mason G, Ruslander DM, Frimberger AE, Wood CA, L'Heureux DA, Gliatto J, Cotter SM. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Internal Med 12 465-470, 1998.
Frimberger AE, Moore AS, Cincotta L, Cotter SM, Foley JW. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clin. Cancer Research 4 2207-2218, 1998.
Kelsey J, Moore AS, Glickman LT. Epidemiologic studies of risk factors for cancer in pet dogs. Epidemiologic Reviews 20 204-217, 1998.
Albers TM, Alroy J, McDonnell JJ, Moore AS. A poorly differentiated gastric carcinoid in a dog. J Vet Diagn. Invest. 10 116-118, 1998
Wood CA, Moore AS, Gliatto JG, Ablin LA, Berg RJ, Rand WM. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J Am Anim Hosp Assoc 34 417-421, 1998.
Vail DM, Moore AS, Ogilvie GK, Volk LM. Feline lymphoma (145 cases): proliferation indices, Cluster of Differentiation 3 immunoreactivity and their association with prognosis in 90 cats receiving therapy. J Vet Internal Med 12 349-354, 1998.
Penninck DG, Moore AS, Gliatto JM. Ultrasonography of canine gastric epithelial neoplasia. Vet Radiology and Ultrasound 39 342-348, 1998
Myers NC, Moore AS, Rand WM, Gliatto J, Cotter SM. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Internal Med 11 333-339, 1998
McCaw DL, Miller MA, Bergman P, Withrow SJ, Moore AS, Knapp DW, Fowler D, Johnson JC. Vincristine therapy for canine mast cell tumors. J Vet Internal Med 11 375-378, 1998
Frimberger AE, Moore AS, LaRue SM, Gliatto JM, Bengtson A. Prognosis for dogs with intermediately differentiated mast cell tumors treated with surgery and orthovoltage or linear accelerator radiation therapy: 40 cases (1990-1994). J Amer Animal Hosp Assoc 33 320-324, 1997.
Mahony OM, Moore AS, Cotter SM, Engler SJ, Penninck DG. Alimentary lymphoma in cats: 28 cases (1988-1993). J Am Vet Med Assoc 207 1593-1598, 1995.
Pirkey-Ehrhart N, Withrow SJ, Straw RC, Ehrhart EJ, Page RL, Hottinger HL, Hahn KA, Morrison WB, Albrecht MR, Hedlund CS, Hammer AS, Holmberg DL, Moore AS, King RR, Klausner JS. Primary rib tumors in 54 dogs. J Am Anim Hosp Assoc 31 65-69, 1995.
Frimberger AE, Moore AS. Treatment of nephroblastoma in a juvenile Bernese Mountain Dog. A case report. J Am Vet Med Assoc 207 596-598, 1995.
Ogilvie GK, Moore AS, Chen C, Ciekot PA, Atwater SW, Bergman PA, Walters LM. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors: a dose escalation study. J Am Vet Med Assoc 205 570-573, 1994.
Watson ADJ, Moore AS, Helfand SC. Primary erythrocytosis in the cat: treatment with hydroxyurea. J Small Anim Pract 35 320-325, 1994.
Penninck DG, Moore AS, Tidwell AS, Matz ME, Freden GO. Ultrasonography of alimentary lymphosarcoma in the cat. Vet Radiol 35 299-304, 1994.
Ruslander D, Moore AS, Gliatto JM, L'Heureux D, Cotter SM. Cytosine arabinoside as a single agent for the induction of remission in canine lymphoma. J Vet Internal Med 8 299-301, 1994.
Ogilvie GK, Moore AS, Obradovich JE, Elmslie RE, Vail DM, Straw RC, Salmon MD, Klein MK, Atwater SW, Ciekot PE, LaRue SM, Peaston A, Withrow SJ. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. J Am Vet Med Assoc 202 1839-1844, 1993.
Spodnick GJ, Berg RJ, Rand WM, Schelling SH, Couto G, Harvey HJ, Henderson RA, MacEwen G, Mauldin N, McCaw DL, Moore AS, Morrison W, Norris AM, O'Bradovich J, O'Keefe DA, Page R, Ruslander D, Klausner J, Straw R, Thompson JP, Withrow SJ. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 200 995-999, 1992.
Theon AP, Madewell BR, Moore AS, Stephens C, Krag DN. Localized thermo-cisplatin therapy: a pilot study in spontaneous canine and feline tumours. Int J Hyperthermia 7 881-892, 1991.
Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF, Withrow SJ. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 198 1618-1621, 1991
Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Curtis CR, Straw RC, Dickinson K, Cooper MF, Withrow SJ. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors. J Am Vet Med Assoc 198 1613-1617, 1991
Ogilvie GK, Moore AS, Curtis CR; Evaluation of cisplatin induced emesis in dogs with malignant neoplasia: 115 cases (1984-1987). J Am Vet Med Assoc 195 1399-1403, 1989.
Middleton DJ, Moore AS, Medhurst CJ; Haemobartonellosis in a dog. Australian Vet J 59 29-30, 1982.
2005
Invited Keynote Speaker: 4 hours. September 2005. European Society of Feline Medicine/SAVAB Feline Congress, Antwerp, Belgium.
"Isn’t it just a recipe? Giving chemotherapy to pets": 1.5 hours. July 1, 2005. Science Week, Australian College of Veterinary Scientists, 2005
Invited Lecturer. 3 hours. May, 2005. World Small Animal Veterinary Association Conference, Mexico City, Mexico.
"Cancer Epidemiology in Companion Animals": 1 hour. April, 2005. VMS 8417 Advanced Oncology, University of Missouri-Columbia
Invited speaker : Cancer Management in Small Animals: 6 hours. ContinuEd Seminars, Kauai, Hawaii
Invited keynote speaker : 13 hours. January 2005. Japanese Veterinary Cancer Society, Tokyo, Japan
2004
Japanese Veterinary Cancer Society, Tokyo, Japan2004
Recent Advances in Cancer Medicine: 4 hours. Science Week, Australian College of Veterinary Scientists, 2004
"Evolving treatments for lymphoma in dogs". Twenty-second Annual ACVIM Veterinary Medical Forum, 2004.
Recent Advances in Feline Medicine: 10 hours. North American Veterinary Conference Post Graduate Institute
Keynote lecture "Chemotherapy in Canine Osteosarcoma": 6 hours. Japanese Society of Clinical Pathology, Tokyo, Japan
2003
State-of-the-art lecture "Advances in the treatment of lymphoma": 9 hours. British Small Animal Veterinary Association, Birmingham, U.K.
Course leader and participant: 4 hours. Tufts International Oncology Symposium, Nassau, New Providence Island
Keynote lecture "Lymphoma": 4 hours. Bayer’s III Veterinary Updating Symposium, Mexico City, Mexico
2002
"Treatment advances for canine osteosarcoma", "Changing treatment for lymphoma in cats". Tufts Animal Expo, Boston MA.
"Angiogenesis opportunities in veterinary medicine: overview and vision". Angiogenesis Foundation Board of Director's Meeting, Cambridge MA.
"Advances in treating soft-tissue sarcomas in dogs and cats", "New treatment strategies for osteosarcoma in dogs", "New treatment strategies for lymphoma in cats", "Streptozotocin for insulinoma", "Risk factors for oral squamous cell carcinoma in cats". The North American Veterinary Conference, 2002. Proc. Vol 16
2001
Invited lecturer, 4 hours. UC Davis Veterinary Endocrinology and Internal Medicine Seminar, Hawaii.
Injection site sarcomas. Focus on cats with cancer: 6 hours. Tufts Animal Expo 2001. Boston MA.
Invited lecturer, 4 hours. Lectures to practitioners in Nagoya and Kobe, Japan.
Invited lecturer, 4 hours. São Paulo State Small Animal Practitioners Meeting. Aguas de Lindoia, Brazil.
2000
Invited lecturer, 3 hours. Tufts Animal Expo 2000. Boston MA
Invited lecturer, 1 hour. Animal Health Trust, Newmarket. U.K.
1999
Invited lecturer, 2 hours. The North American Veterinary Conference, 1999. Proc. Vol 13
Site coordinator for European College of Veterinary Internal Medicine and the Veterinary Cancer Society Annual Meeting, Woods Hole, MA
Invited lecturer, 7 hours. World Animal Hospital Association; Tokyo, Kyoto, Niigata, Nagoya, Sendai, and Osaka, Japan.
1998
Veterinary Forum: Round table discussion: “Compassionate cancer care” Am Vet Med Assoc Meeting. Baltimore MD.
Invited lecturer, 2 hours. Lectures to practitioners, Kourakuen, Asakusa and Kozukue, Japan.
Keynote Address: Management of canine and feline mast cell tumors. Seventh Annual Conference of the Japan Veterinary Cancer Society, Kanagawa, Japan.
1997
Invited lecturer, 3 hours. Small Animal Oncology Conference, University of Zurich, Switzerland.
1996
Oral and intravenous administration of 9-aminocamptothecin to dogs with lymphoma: preliminary findings. Pharmacia & Upjohn 9-AC Workshop, Philadelphia PA.
Invited lecturer, 4 hours. Western States Veterinary Conference, 68th Annual Conference.
1995
Invited Participant: Paradigms in cancer biology and cancer therapy. Krasnow Institute for Advanced Study; George Mason University, Airlie, VA.
1994
Course Director: Treatment of cancer in Companion Animals. Postgraduate Committee in Veterinary Science, Sydney, Australia.